Emerging and unusual gram-negative infections in cystic fibrosis.
about
Got black swimming dots in your cell culture? Identification of Achromobacter as a novel cell culture contaminantReducing virulence of the human pathogen Burkholderia by altering the substrate specificity of the quorum-quenching acylase PvdQActivity and interactions of liposomal antibiotics in presence of polyanions and sputum of patients with cystic fibrosisFirst time identification of Pandoraea sputorum from a patient with cystic fibrosis in Argentina: a case reportAirway infection with a novel Cupriavidus species in persons with cystic fibrosis.Achromobacter xylosoxidans genomic characterization and correlation of randomly amplified polymorphic DNA profiles with relevant clinical features [corrected] of cystic fibrosis patients.The changing microbial epidemiology in cystic fibrosis.Phenotypic and genotypic characterization of Stenotrophomonas maltophilia isolates from patients with cystic fibrosis: genome diversity, biofilm formation, and virulence.Implantable cardiac defibrillator pocket infection due to a previously undescribed Cupriavidus species.Clinical and microbiological features of a cystic fibrosis patient chronically colonized with Pandoraea sputorum identified by combining 16S rRNA sequencing and matrix-assisted laser desorption ionization-time of flight mass spectrometry.Anatomical localization of commensal bacteria in immune cell homeostasis and diseaseClinical significance of microbial infection and adaptation in cystic fibrosis.Stenotrophomonas maltophilia virulence and specific variations in trace elements during acute lung infection: implications in cystic fibrosis.Stenotrophomonas maltophilia strains replicate and persist in the murine lung, but to significantly different degreesPseudomonas aeruginosa AmpR: an acute-chronic switch regulator.Achromobacter Species Isolated from Cystic Fibrosis Patients Reveal Distinctly Different Biofilm MorphotypesDeveloping an international Pseudomonas aeruginosa reference panel.A compositional look at the human gastrointestinal microbiome and immune activation parameters in HIV infected subjects.Update on antibiotics for infection control in cystic fibrosis.Differences in Gene Expression Profiles between Early and Late Isolates in Monospecies Achromobacter Biofilm.A specific polymerase chain reaction method to identify Stenotrophomonas maltophilia.A pan-genomic approach to understand the basis of host adaptation in Achromobacter.Draft Genome Sequence of Triclosan-Resistant Cystic Fibrosis Isolate Achromobacter xylosoxidans CF304.Isolation and characterization of numerous novel phages targeting diverse strains of the ubiquitous and opportunistic pathogen Achromobacter xylosoxidans.EuroCareCF quality assessment of diagnostic microbiology of cystic fibrosis isolates.Multilocus sequence analysis of isolates of Achromobacter from patients with cystic fibrosis reveals infecting species other than Achromobacter xylosoxidans.Prevalence of Achromobacter xylosoxidans in pulmonary mucosa-associated lymphoid tissue lymphoma in different regions of Europe.Molecular Characterization of Stenotrophomonas maltophilia isolates from cystic fibrosis patients and the hospital environment.Identification and management of unusual pathogens in cystic fibrosis
P2860
Q24604229-DE9383F2-B054-45CF-A88C-B788085F2E8BQ27681506-3AA9DCF5-DB1C-47E1-BC64-9892E25DD3D3Q28475562-9F450E57-A43E-4C64-A33E-ABD23DC02077Q28817223-A53C42BD-05DE-44C9-9804-7B3391A6FA08Q33482631-A4401A08-66A1-4642-94FD-CC0F7901AA47Q33769610-AE059721-6F0A-416C-A5F7-C23F565AB86DQ33825634-C8CA6558-C5D5-43F0-AD46-FFF6326C2020Q33950924-AD63A07F-9D46-47F8-BB5B-9DCE3260942BQ33963731-3592DD84-68F0-48D0-AAD8-D99E2736B05DQ34101572-4E6251C2-F801-4449-9648-6E482C5D6CDFQ34425509-2951D17C-62D5-42CE-92D3-B6AB628E6D15Q34491552-7D829CCF-A12A-4C2B-B5D2-F75742EF11E4Q35106279-801C3752-B8AF-4C39-9E86-DDF7FB36CB15Q35199103-33D9B17C-D5DD-4EB8-8D79-AD532D653FFDQ35975439-45B44F19-A8BF-4AFE-ADDE-515E5C1753B2Q37291057-AC69B1A3-0C93-453E-83C9-99C3DD8BAA2DQ37480979-FD62A5FF-CF3B-4380-AA58-7839626EE6B1Q37595511-5375B713-429D-4C63-B97F-DB7CB4EF42E7Q37608274-96BB0F1F-DD54-4585-9BBB-598C3C53DC07Q38769173-7F0DF26A-1B5E-433B-84BB-7A1896D3BD9AQ39092623-9F59A99E-197D-4BC7-A456-70E63F60F6C7Q40262334-48750192-7189-43AF-8300-EC585442E992Q41820544-9579C1DB-C4DC-490D-8FC2-D6A9D08CDC7EQ41886330-6F93E924-1CEA-4C06-89DB-771A20B9E3F4Q41908042-0CA77CD3-3CA2-4169-A9B5-8D86D1BFE90EQ41977509-09E06924-757D-446F-908F-920C3C7F08D3Q42234991-33884592-C69E-41F4-86BC-9411A2462F29Q46520702-EE00BAD0-D24C-4EAB-9139-0F275122654AQ57913664-D261FF2C-EBE2-4C10-8072-B9D04BB4333A
P2860
Emerging and unusual gram-negative infections in cystic fibrosis.
description
2007 nî lūn-bûn
@nan
2007 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Emerging and unusual gram-negative infections in cystic fibrosis.
@ast
Emerging and unusual gram-negative infections in cystic fibrosis.
@en
type
label
Emerging and unusual gram-negative infections in cystic fibrosis.
@ast
Emerging and unusual gram-negative infections in cystic fibrosis.
@en
prefLabel
Emerging and unusual gram-negative infections in cystic fibrosis.
@ast
Emerging and unusual gram-negative infections in cystic fibrosis.
@en
P356
P1476
Emerging and unusual gram-negative infections in cystic fibrosis.
@en
P2093
Bruce K Rubin
Jane C Davies
P304
P356
10.1055/S-2007-981652
P577
2007-06-01T00:00:00Z